Cargando…
Ginsenoside compound K inhibits nuclear factor-kappa B by targeting Annexin A2
BACKGROUND: Ginsenoside compound K(C-K), a major metabolite of ginsenoside, exhibits anticancer activity in various cancer cells and animal models. A cell signaling study has shown that C-K inhibited nuclear factor-kappa B (NF-κB) pathway in human astroglial cells and liver cancer cells. However, th...
Autores principales: | Wang, Yu-Shi, Zhu, Hongyan, Li, He, Li, Yang, Zhao, Bing, Jin, Ying-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6606818/ https://www.ncbi.nlm.nih.gov/pubmed/31308817 http://dx.doi.org/10.1016/j.jgr.2018.04.002 |
Ejemplares similares
-
(20S) Ginsenoside Rh2 Inhibits STAT3/VEGF Signaling by Targeting Annexin A2
por: Wang, Yu-Shi, et al.
Publicado: (2021) -
Identification of natural compounds targeting Annexin A2 with an anti-cancer effect
por: Wang, Yu-Shi, et al.
Publicado: (2018) -
Genome-scale CRISPR screening for potential targets of ginsenoside compound K
por: Yang, Yuanyuan, et al.
Publicado: (2020) -
Ginsenoside compound K alleviates osteoarthritis by inhibiting NLRP3‑mediated pyroptosis
por: Li, Yuguo, et al.
Publicado: (2023) -
The dichotomy of inhibiting nuclear factor kappa-B in pneumonia
por: Abraham, Edward
Publicado: (2013)